Usana Health Sciences USNA

NYSE · Medicinal Chemicals & Botanical Products · $251M
$13.16−0.45%Nov 19 close · Databento
Every report since 2023 →
TradingView’s own chart and price feed. The page’s numbers are end-of-day closes.

Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.

The numbers

fiscal 2026, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$251M
EV / FCF10.5x
Revenue$925.3M +8.3%
True FCF (ex-SBC)$-5.3M −83.3%
Rule of 409.2%
ROIC2.8%
True FCF Yield-2.1%
EPS, diluted$0.58 −73.5%
Modern Valuation (EOD)
Market Cap$251M
Enterprise Value$89.5M
EV / True FCF—
EV / FCF10.50
EV / Gross Profit0.12
EV / EBIT2.39
EV / Sales0.10
P / E (GAAP)23.30
P / FCF29.41
P / Oper. CF11.22
P / Book0.47
Owner & Cash Yields
True FCF Yield-2.1%
FCF Yield3.4%
Owner Earn. Yield6.3%
Earnings Yield4.3%
Shareholder Yield+5.5%
Buyback Yield11.0%
Dividend Yield—
Dividend / sh—
Payout Ratio—
FCF / sh$0.46
EPS (diluted)$0.58
Compounder & Returns
Rule of 409.2%
ROIC2.8%
Cash ROIC (CROIC)2.3%
GP / Assets97.5%
ROE2.0%
ROA1.4%
Gross Margin78.3%
Oper. Margin4.0%
Net Margin1.2%
FCF Margin0.9%
True FCF Margin-0.6%
Quality & Dilution
Cash Conversion79%
Accrual Ratio−1.6%
SBC % of FCF162.2%
SBC % of Rev1.5%
Reinvest. Rate110%
Sales Growth Y/Y+8.3%
Sales 3Y CAGR−2.5%
EPS Growth Y/Y−73.5%
FCF Growth Y/Y−83.3%
FCF 3Y CAGR−55.0%
Share Change Y/Y−3.1%
Balance Sheet & Scale
Revenue (FY)$925.3M
Gross Profit (FY)$724.4M
Oper. Income (FY)$37.4M
GAAP Net Income$10.8M
True FCF (ex-SBC)$-5.3M
Cash & Equiv$161.2M
Total Debt—
Net Cash (Debt)$161.2M
Net Cash % MCap+64.3%
Debt / FCF (yrs)—
Current Ratio2.2418.49M sh
Price & Technicals (EOD)
Perf Week+3.38%
Perf Month−7.45%
Perf Quarter−2.88%
Perf Half Y−29.09%
Perf YTD−29.09%
SMA 20 Dist−4.64%$13.80
SMA 50 Dist−8.39%$14.37
SMA 100 Dist−18.50%$16.15
Window High−43.37%$23.24
Window Low+3.38%$12.73
RSI (14) · Vol40.042%v
Income Distribution & Cash Flow ConversionHow every dollar of USNA revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
REVENUE · 100%$925.3MGROSS PROFIT · 78.3%$724.4MCOST OF REV · 21.7%$200.9MOPER. INCOME · 4.0%$37.4MOPEX · 74.2%R&D $10.7M · SG&A $337.4MNET INCOME · 1.2%$10.8M
Where Every $100 of Revenue Goes (FY2026)
Cost of Revenue (COGS)$200.9M ($21.7 / $100)
R&D Reinvestment$10.7M ($1.2 / $100)
SG&A & Other OpEx$676.3M ($73.1 / $100)
Tax & Non-Operating$26.7M ($2.9 / $100)
Net Profit Kept$10.8M ($1.2 / $100)
Earnings Quality: GAAP Profit → True Owner Cash (FY2026)
GAAP Net Income$10.8M (1.2% margin)
Operating Cash Flow (OCF)$22.3M(2.4% of rev)
Less: Capital Expenditures−$13.8M(1.5% of rev)
Standard Free Cash Flow (FCF)$8.5M(0.9% margin)
Less: Stock-Based Comp (SBC)−$13.8M(162.2% of FCF)
True FCF (Owner Cash ex-SBC)$-5.3M(-0.6% of rev)

Operating leverage — margins

GrossOperatingNet
0%45%90%78%4%1%FY22FY22FY23FY24FY26
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)FY2022FY2022FY2023FY2024FY2026YoY Δ4Y CAGRTrend
Income Statement
Cost of Revenue (COGS)$217.9M$193.9M$176.7M$161.2M$200.9M+24.6%−2.0%
Research & Development (R&D)$11.1M$11.6M$11.4M$11.6M$10.7M−7.6%−1.0%
Selling, General & Admin (SG&A)$279.1M$262.3M$257.0M$263.3M$337.4M+28.1%+4.9%
Total Operating Expenses$798.4M$697.1M$651.2M$627.0M$687.0M+9.6%−3.7%
Interest Expense$57,000$192,000$262,000$281,000$842,000+199.6%+96.0%
Income Tax Expense$54.1M$39.3M$38.7M$34.3M$30.1M−12.4%−13.7%
Diluted Shares20.3M19.3M19.3M19.2M18.6M−3.1%−2.2%
Balance Sheet
Cash & Equivalents$243.7M$291.3M$333.2M$184.5M$161.2M−12.6%−9.8%
Inventory$98.3M$67.1M$61.5M$69.7M$102.6M+47.1%+1.1%
Total Current Assets$365.1M$384.4M$417.7M$279.2M$288.4M+3.3%−5.7%
Total Assets$577.7M$596.5M$632.8M$748.2M$742.9M−0.7%+6.5%
Total Current Liabilities$160.8M$143.8M$118.8M$139.6M$128.6M−7.9%−5.4%
Total Liabilities$138.4M$138.4M$135.6M$161.9M$156.6M−3.2%+3.1%
Stockholders' Equity$395.1M$434.5M$497.2M$532.1M$533.1M+0.2%+7.8%
Net Cash / (Net Debt)$243.7M$291.3M$333.2M$184.5M$161.2M−12.6%−9.8%
Invested Capital$151.5M$143.2M$164.0M$347.6M$371.9M+7.0%+25.2%
Cash Flow & Capital Allocation
Depreciation & Amortization (D&A)$13.0M$13.4M$12.7M$14.5M$32.6M+124.0%+25.7%
Stock-Based Compensation (SBC)$14.3M$13.3M$14.6M$14.6M$13.8M−5.0%−0.8%
Capital Expenditures (CapEx)$12.8M$10.4M$14.5M$10.1M$13.8M+37.2%+2.0%
True FCF (ex-SBC Owner Cash)$94.2M$80.2M$41.6M$36.4M$-5.3M−114.6%—
Share Repurchases (Buybacks)$177.8M$25.4M$11.6M$9.4M$27.5M+191.3%−37.3%

Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.

On the Wire

what USNA did at the next close after each story

No Wire story has named USNA yet.

The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.